Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stojdl

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2012
Molecular pathways: multimodal cancer-killing mechanisms employed by oncolytic vesiculovirusesDouglas J Mahoney, David F Stojdl
Future Oncology (London, England)|March 14, 2012
Fighting fire with fire: rewiring tumor cells for oncolytic virotherapyDouglas J Mahoney, David F Stojdl
Viruses|February 11, 2016
Big Data Offers Novel Insights for Oncolytic Virus ImmunotherapyStephanie L Swift, David F Stojdl
Scientific American|December 4, 2014
Virus therapy for cancerDouglas J Mahoney, David F Stojdl, Gordon Laird
Oncolytic Virotherapy|September 1, 2016
High-throughput screening to enhance oncolytic virus immunotherapyK J Allan, David F Stojdl, S L Swift
Trends in Molecular Medicine|May 4, 2004
Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.
Nature Reviews. Cancer|July 4, 2014
Going viral with cancer immunotherapyBrian D Lichty, Caroline J Breitbach, David F Stojdl, et al.
Molecular Therapy Oncolytics|September 13, 2021
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus developmentTiffany Y Ho, David Mealiea, Lili Okamoto, et al.
Journal of Visualized Experiments : Jove|April 24, 2018
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus TherapyKristina J Allan, Douglas J Mahoney, Stephen D Baird, et al.
International Journal of Molecular Sciences|February 1, 2019
Characterizing Cellular Responses During Oncolytic Maraba Virus InfectionGolnoush Hassanzadeh, Thet Naing, Tyson Graber, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2012
Molecular pathways: multimodal cancer-killing mechanisms employed by oncolytic vesiculovirusesDouglas J Mahoney, David F Stojdl
Future Oncology (London, England)|March 14, 2012
Fighting fire with fire: rewiring tumor cells for oncolytic virotherapyDouglas J Mahoney, David F Stojdl
Viruses|February 11, 2016
Big Data Offers Novel Insights for Oncolytic Virus ImmunotherapyStephanie L Swift, David F Stojdl
Scientific American|December 4, 2014
Virus therapy for cancerDouglas J Mahoney, David F Stojdl, Gordon Laird
Oncolytic Virotherapy|September 1, 2016
High-throughput screening to enhance oncolytic virus immunotherapyK J Allan, David F Stojdl, S L Swift
Trends in Molecular Medicine|May 4, 2004
Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.
Nature Reviews. Cancer|July 4, 2014
Going viral with cancer immunotherapyBrian D Lichty, Caroline J Breitbach, David F Stojdl, et al.
Molecular Therapy Oncolytics|September 13, 2021
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus developmentTiffany Y Ho, David Mealiea, Lili Okamoto, et al.
Journal of Visualized Experiments : Jove|April 24, 2018
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus TherapyKristina J Allan, Douglas J Mahoney, Stephen D Baird, et al.
International Journal of Molecular Sciences|February 1, 2019
Characterizing Cellular Responses During Oncolytic Maraba Virus InfectionGolnoush Hassanzadeh, Thet Naing, Tyson Graber, et al.
Pageof 4